BioPharmSignal logoBioPharmSignal

Biotech News

Forian Receives Unsolicited Proposal from CEO to be Taken Private

Forian (FORA)ForianCompany update

NEWTOWN, PA - August 25, 2025 (NEWMEDIAWIRE) - Forian Inc. (NASDAQ:FORA) (“Forian” or the “Company”), a leading provider of data science driven information and analytics solutions to the life science, healthcare and financial services industries, announced today that its Board of Directors has received an unsolicited, preliminary, non-binding proposal letter, dated August 25, 2025, from a group led by Forian...

Related news

FORAForian2021-09-01 16:15 EST

Forian Inc. Announces $24 Million Private Placement of 3.5% Convertible Notes due 2025, Appoints New Chief Financial Officer

FORAForian2021-04-12 17:54 EST

Forian Inc. Announces $12 Million Private Placement of Common Stock

View all latest news

Forian

Forian is a healthcare data and analytics company focused on information services, software, and workflow tools. Its business is about using data infrastructure to support healthcare and life-sciences decisions.

Recent company news

FORAForian2025-10-30 17:36 EST

Forian Inc. to Announce Third Quarter 2025 Results on November 14, 2025

FORAForian2025-08-25 13:06 EST

Forian Receives Unsolicited Proposal from CEO to be Taken Private

FORAForian2025-05-06 16:33 EST

Forian Inc. to Announce First Quarter 2025 Results on May 14, 2025

FORAForian2024-12-16 08:00 EST

Forian Partners With Databricks to Expand Access to Advanced Healthcare Analytics

FORAForian2024-11-13 16:00 EST

Forian Inc. Announces Third Quarter 2024 Financial Results

Stock data

Close
2.17 USD
Market cap
67.79M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States